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Abstract
Background & Aims: There is a worldwide epidemic of obesity among adolescents who subsequently are at increased risk
for the development of non alcoholic fatty liver disease (NAFLD). The serum alanine aminotransferase (ALT) is the most
frequently used test for screening these individuals, but no age and gender-specific upper limits of normal (ULN) based on
healthy population data in children are available. The objective of the present study was to define ULN for ALT in healthy
children in order to use this as a tool for case finding.
Methods: A total of 975 school children (aged 7–18 years) were included in the study cohort. Highly significant correlations
(all p,0.001) were noted between ALT values and measures of BMI, systolic and diastolic blood pressure, insulin levels,
HOMA-IR, total cholesterol and triglyceride concentrations. In order to define the population with no risk factors, we
excluded subjects having abnormal values for factors that correlated with ALT. This population comprised 186 boys and 185
girls.
Results: In boys, median serum ALT levels were 16 IU/L and 9, 11, 18, and 30 IU/L for the 5th, 25th, 75th, and 95th
percentiles. In girls, median serum ALT was 13, and 7, 9, 16, and 21 IU/L for the 5th, 25th, 75th, and 95th percentiles,
respectively. The ULNs for ALT were 30 IU/L and 21 IU/L for boys and girls respectively. We found a linear relationship
between age and ALT in females (p,0.001) but not in males. By multiple logistic regression, independent predictors of an
elevated ALT included the BMI, waist hip ratio and levels of serum total cholesterol. In females, age was an additional inverse
predictor.
Conclusions: In children and adolescents, these normal limits for ALT should be applied. Those with persistent elevations
should be investigated further.
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Introduction
There is a worldwide epidemic of obesity and diabetes, with an
estimated 1 billion overweight adults [1]. Likewise, childhood
obesity is increasing, with the development of end-organ damage
in children and young adults [2,3]. The spectrum of disorders
related to adiposity is myriad, but includes insulin resistance, type
2 diabetes mellitus (T2DM), cardiovascular disease and fatty liver
disease [4–9]. A central issue related to the management of
obesity-related chronic diseases concerns laboratory screening and
diagnosis. The serum alanine aminotransferase (ALT) activity
correlates with obesity [10], reflects hepatocellular injury and is
the most frequent test for screening and monitoring patients with
non alcoholic fatty liver disease (NAFLD) [11]. Since NAFLD is a
component of the metabolic syndrome and its consequences, it is
not surprising that elevations in ALT activity are frequently
present in persons with T2DM and cardiovascular disease and are
associated with increased mortality [11–17].
Liver functions tests are the most frequently ordered tests in
clinical practice, being relatively cheap and easy to measure. Of the
panel, the ALT is the most specific screening test for hepatic necro-
inflammation. Elevations in ALT activity usually reflect the presence
of NAFLD, if other causes have been excluded. Data from pediatric
studies indicate that NAFLD is an emergent problem, which in a
proportion of cases, may progress to cirrhosis and liver-related
morbidity and mortality [18]. Even in patients that do not develop
advanced liver disease, an elevated ALT is an important surrogate
for cardio-metabolic risk including dyslipidemia, hypertension and
glucose intolerance. These patients are more likely to die of
cardiovascular disease than from liver disease [19–25].
In screening for NAFLD, the quoted laboratory reference
intervals for ALT serve as an important decision making tool
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21178[26,27]. It has also been demonstrated that age and gender have
significant effects on the levels of serum ALT and AST, with an
inverted U pattern with respect to age [11,28–30]. However, age
and gender-specific upper limits of normal for the AST and ALT
based on healthy population data in children are currently not
available. Hence, the objective of the present study was to define
upper limits of normal (ULN) for aminotransferases in healthy
school age children in order to (1) define cut-offs for screening in
primary and specialist health care settings and (2) to use this as a
tool for early intervention in the management of fatty liver disease
and as well, other complications of the metabolic syndrome.
Results
Of 1000 students who consented to participate, 74 were
excluded as they were unable to fast overnight. Another student
was excluded after testing positive for hepatitis B surface antigen
(HBsAg). None of students were positive for hepatitis C antibody
and all subjects denied cigarette smoking or alcohol consumption.
Hence, the data presented is based on a cohort of 925 individuals.
Table 1 presents baseline demographic data for the whole cohort
including age, gender BMI, HOMA-IR, blood pressure, ALT and
AST level, and fasting glucose, fasting lipid profile and fasting
insulin. The age and gender distribution of the students who
agreed to participate in the study were no different from those that
declined.
We next determined whether any of the clinical and laboratory
parameters measured correlated with the values for serum ALT.
As noted (Table 2), highly significant and positive correlations (all
p,0.001) were noted between the serum ALT and measures of
BMI, systolic and diastolic blood pressure, insulin levels, calculated
HOMA-IR, total cholesterol and triglyceride concentrations. In
contrast, there was a weak but inverse correlation between ALT
and age (spearman r 20.077; p,0.021).
In order to define the population with no risk factors for
metabolic liver disease, we first excluded all subjects having
abnormal values for factors correlated with ALT based on the
definitions described earlier. This group, the healthy population,
comprised of 186 boys and 185 girls and had values for fasting
glucose, insulin levels, the total cholesterol and triglyceride within
the normal range (8067 mg/dl, 1264 mU/ml, 141617 mg/dl,
66616 mg/dl, respectively. Table 1 lists the baseline character-
istics of the total study cohort and of the healthy population.
We next defined the normal range and mean values for ALT
and AST in these 371 normal subjects. Table 3 lists the median,
mean and range for serum ALT and AST according to gender,
and as well the percentiles for these values. In boys, serum ALT
levels were 16 IU/L for the median, and 9, 11, 18, and 30 IU/L
for the 5
th,2 5
th,7 5
th, and 95
th percentiles, respectively. Serum
AST levels were 26 for the median, and 17, 23, 30, and 38 IU/L
for the 5
th,2 5
th,7 5
th, and 95
th percentiles, respectively. In girls,
serum ALT levels were 13 for the median, and 7, 8.6, 16, and 20.8
IU/L for the 5
th,2 5
th,7 5
th, and 95
th percentiles, respectively.
Serum AST levels were 21 for the median, and 14, 18, 25, and
32.7 IU/L for the 5
th,2 5
th,7 5
th, and 95
th percentiles, respectively.
Values below the gender-specific 95
th percentile were used to
define the upper limit of normal value for the ALT and AST in
boys and girls. Based on this definition, the ULNs for ALT were
30 IU/L and 21 IU/L for boys and girls respectively, while the
ULNs for AST were 38 IU/L and 33 IU/L for boys and girls
respectively. Gender-specific histograms of each of these values are
presented in Figure 1.
In further analysis we found a linear relationship between age
and ALT in females (p,0.001) but relationship for males was not
significant (p=0.41). Therefore, based on this finding we
calculated 5th and 95th percentiles and predicted values for
ALT by age in females (Figure 2).
We next categorized females into three age groups: group a) 7–
10 years (n=41), group b) 11–14 (n=57) and group c) 15–18 years
(n=76) and calculated a separate range of ALT for each group.
The minimum and maximum values for these three groups were 8,
8, 7 and 24, 22, 20 respectively for girls aged 7–10 years, 11–14
and 15–18 years.
As shown in Table 2, ALT values were correlated with several
anthropometric and laboratory variables. In order to determine
which factors were independently associated with elevations in
ALT (segregated by gender), we undertook multiple logistic
regression analysis with input variables that included age, BMI,
SBP, DBP, Total TG, total cholesterol, HOMA-IR and LDL
Table 1. Baseline characteristics of the total cohort and the ‘healthy’ population.
Variables Whole cohort (n=925) Healthy subjects (371)
All mean (SD) Male mean (SD) Female mean (SD) All mean (SD) Male mean (SD) Female mean (SD)
Age (yrs) 12.92 (3) 12.80 (2) 13 (3) 12.87 (3.13) 12.58 (3) 13.17 (3.41)
BMI (kg/m
2) 20.45 (4.75) 19.89 (4.72) 20.88 (4.7) 18 (2.63) 17.59 (2.47) 18.41 (2.74)
HOMA-IR 3.12 (1.8) 3.15 (1.9) 3.08 (1.7) 2.43 (0.92) 2.43 (1.01) 2.43 (0.82)
SBP 10.53 (1.05) 10.8 (1.05) 10.33 (10) 10.21 (0.90) 10.39 (0.86) 10.03 (0.91)
DBP 6.50 (0.61) 6.65 (0.66) 6.38 (0.54) 6.35 (0.54) 6.47 (0.60) 6.23 (0.54)
ALT (IU/L) 17.21 (10.23) 19.96 (11.40) 15.01 (8.6) 14.84 (5.33) 16.63 (5.76) 13.04 (4.15)
AST (IU/L) 24.68 (12.47) 27.23 (8.44) 22.64 (14.62) 24.37 (6.39) 26.69 (6.43) 22.04 (5.45)
Fasting glucose (mg/dl) 81.05 (10.78) 82.95 (7.58) 79.53 (12.57) 80.13 (7.45) 81.99 (7.05) 78.25 (7.39)
Insulin(mU/ml) 15.30 (7.23) 14 (7.85) 15.54 (6.7) 12.22 (4.30) 11.90 (4.5) 12.54 (3.99)
T-C (mg/dl) 154.90 (27) 152.28 (26.9) 156.98 (26.97) 141.09 (16.95) 137.81 (16.21) 144.40 (17.08)
TG (mg/dl) 87.68 (41.51) 85.85 (42.18) 89.15 (40.95) 65.76 (15.73) 65.13 (16.29) 66.40 (15.16)
LDL (mg/dl) 88.55 (19.62) 86.32 (19.36) 90.32 (19.66) 79.97 (13.09) 77.50 (12.31) 82.45 (13.42)
Abbreviations: ALT: alanine aminotransferase, AST: aspartate aminotransferase, BMI: body mass index, HOMA-IR: homeostasis model assessment of insulin resistance,
LDL: low-density lipoprotein, SD: standard deviation, T-C: Total cholesterol, TG: Triglyceride.
doi:10.1371/journal.pone.0021178.t001
Healthy Ranges for Alanine Aminotransferase Levels
PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e21178cholesterol. As shown in Table 4, independent predictors of an
elevated ALT as expected included the BMI, the waist hip ratio
and levels of serum total cholesterol. In females, age was an
additional inverse predictor. Again, as shown in the table, visceral
obesity as measured by the waist hip ratio was a stronger predictor
of elevations in ALT (OR 2.25 CI1.4–3.56 in boys and 1.8 CI
1.16–2.8 in girls) than the BMI.
In the final analysis, we compared the number of components of
the metabolic syndrome in the group with normal and elevated
ALT levels based on ULNs calculated in the current study. As
shown in Table 5, ALT values were similar between those who
had only one component of the metabolic syndrome and those
who did not (p=0.385). In contrast, those with 2 or more
components of the metabolic syndrome had elevated ALT levels
(p,0.001). The metabolic syndrome was present in 7% of those
with a normal ALT, but in 21% of those with an elevated ALT.
Discussion
In this study we undertook an age- and gender-based approach
to define upper limits of normal for ALT and AST in school aged
children and adolescents. In boys, ULNs for ALT and AST were
30 and 38 IU/L respectively. In girls the ULN for ALT and AST
were 21 and 33 IU/L, respectively, and in this group ULNs for
ALT (but not for AST) was inversely associated with age. In girls
therefore, the ULN for ALT was 24 IU/L (age 7–10 years), 22
IU/L (11–14 years), and 20 IU/L (15–18 years). In multiple
logistic regression analysis, serum total cholesterol, BMI and waist
to hip ratio were independent predictors of an elevated ALT.
In defining reference intervals, identifying a group of healthy
individuals is of paramount importance. For determining ULNs
for ALT and AST therefore, subjects should be free of risk factors
for liver diseases. In affluent nations, the most common liver
disease in children and adolescents is NAFLD with a rate between
2.6% to 9.8% [31,32]. The prevalence of NAFLD in the
aforementioned age group in Iran is comparable, with a rate
between 2.3% to 7.1% [33,34]. Since Iran is located in an
intermediate zone for HBV, we checked for hepatitis B surface
antigen and to exclude HCV infection, anti-HCV antibody was
assessed.
To determine ranges of ALT and AST in healthy children and
adolescents, we next assessed for factors associated with serum
ALT in univariate analysis. BMI, systolic and diastolic blood
pressure, insulin levels, calculated HOMA-IR, the total choles-
terol and triglyceride concentrations correlated with the serum
ALT. Therefore, participants who had abnormal results for these
components based on age-specific published values were
excluded. In addition, those with elevated blood pressure or
blood glucose were excluded and as discussed earlier, none of the
subjects consumed alcohol or smoked cigarettes. Thus, the ULN
values quoted for healthy children and adolescents in this study
are likely to reflect true normative values at this age and are in
accordance with studies published from elsewhere [35,36]. Our
sample size, we believe, is adequate for this purpose based on a
consensus document produced by the Clinical and Laboratory
Standards Institute (CLSI), formally known as the NCCLS [37].
They suggest that 120 is the minimum number of samples
needed to establish a reference range to have a 90% confidence
interval for the 97.5th percentile. Moreover if 198 samples are
used then the confidence interval for the 97.5th percentile
becomes 99%.
The upper limit of normal for ALT and AST in boys was higher
than in girls. The reason for this is not known, but could relate to
differences in muscle mass and sex hormones between genders. In
this regard, it is well established that serum concentrations of
estradiol are low in preadolescent girls and increase at menarche,
while after menopause, serum concentrations decline to the levels
below or similar to that in men [38]. These age-related hormonal
changes could in part account for the reductions in the ULN of
ALT that we observed in girls.
Considering the association between abnormal ALT values,
cardiovascular disease, type 2 diabetes and NAFLD, our gender-
specific reference ranges could help preventive health care systems
in case ascertainment of children at higher risk of future morbidity.
Consistent with this, we have shown that ALT levels were elevated
in those with two or more components of the metabolic syndrome.
Therefore, encountering elevated ALT values should prompt a
thorough assessment of cardio-metabolic risk and the institution of
preventive measures including lifestyle change and pharmacother-
apy [32].
Our study has limitations in that we stratified normative ALT
values in girls according to age, but had less than the 120 persons
in each category as recommended by the Expert Panel on
reference values [39]. However, studies such as the present one are
Table 3. Normal ranges for liver chemistry by gender in 371
healthy subjects.
ALT (IU/L) AST (IU/L)
Male (186) Female (185) Male (186) Female (185)
Mean 16.63 13.05 26.7 22.05
Median 16 13 26 21
Min 8 5 4 13
Max 39 31 47 39
Percentile
59 7 1 71 4
25 11 8.6 23 18
75 18 16 30 25
95 30 20.7 38 32.7
P,0.001 for difference in mean values of ALT and AST in males and females.
doi:10.1371/journal.pone.0021178.t003
Table 2. Factors correlated with ALT level in 925 students.
Age BMI SBP DBP Insulin HOMA-IR T-C TG
Spearman 20.077 0.169 0.198 0.181 0.136 0.124 0.148 0.164
P value 0.021 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001
Abbreviations: BMI: Body mass index; HOMA-IR: homeostasis model assessment of insulin resistance; DBP: diastolic blood pressure; SBP: systolic blood pressure; T-C:
Total cholesterol; TG: Triglyceride.
doi:10.1371/journal.pone.0021178.t002
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pubertal stages would have been ideal, but this was not ethically
feasible.
In conclusion, we have used rigorous criteria to define normal
values for serum aminotransferases in children. These limits
should be routinely used when assessing children and adolescents.
Further, we suggest that those with persistent elevations should be
assessed for the metabolic syndrome and its components (if viral
hepatitis has been excluded), and managed aggressively to improve
long term health outcomes and quality of life.
Methods
The study protocol was approved by the Ethics Council of the
Iran Ministry of Health and Medical Education. The study
population was selected using a stratified multistage random
sampling design according to the age, gender and geographic
location of children from the city of Tehran, Iran. For this study,
Tehran was divided into 5 geographic regions. Written invitations
were sent to 11,000 randomly selected students from public school
registries in the 5 regions. A stratified cluster random sampling
Figure 1. Histograms defining normal values for ALT and AST by gender in 371 healthy students.
doi:10.1371/journal.pone.0021178.g001
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Ultimately, 1,000 students aged 7–18 were enrolled in the study.
Written informed consent was obtained from parents and oral
consent from students after full explanation of the procedures. For
blood sampling, students were invited to the Children’s Medical
Centre and one of the parents accompanied his/her child. Each
student was initially assessed by a trained nurse who administered
a questionnaire to obtain information on demographic variables,
the medical history, dietary habits, alcohol consumption and
cigarette smoking. Ten ml of venous blood was taken from an
ante-cubital vein in clotted tubes, placed in ice and transported to
the reference laboratory. All laboratory assessments were per-
formed on the same day. All subjects subsequently underwent a
liver ultrasound by an expert radiologist.
Body weight was measured in all students in the upright position
to the nearest 0.1 kg while wearing light clothing without shoes.
Height was measured to the nearest millimeter with a portable
stadiometer. Waist circumference was measured at the end of
normal expiration to the nearest millimeter, at the narrowest point
between the lower borders of the rib cage and the iliac crest. Hip
circumference was obtained at the widest point between hip and
buttock.
Blood pressure was measured using a mercury sphygmoma-
nometer after confirming that subjects did not consume caffeine or
smoke cigarettes 30 min prior to the measurement. All subjects
were seated for at least 5 minutes. The first and fifth Korotkoff
sounds were recorded as the systolic blood pressure (SBP) and the
diastolic blood pressure (DBP), respectively. This was measured
twice and the mean used in the analysis.
Plasma concentrations of glucose, total cholesterol, triglyceride,
high density lipoprotein (HDL) cholesterol, AST, ALT and insulin
were measured using an auto analyzer (Hitachi 912 auto-analyzer,
Tokyo, Japan). All subjects were checked for hepatitis B surface
antigen (HBsAg) and anti-HCV antibody (HCVAb).
The body mass index (BMI) was calculated as weight divided by
the height in meters squared (kg/m
2). Gender-specific BMI cut-off
values based on 6 nationally representative data sets were used to
define overweight and obesity in children [40].
Figure 2. 95
th percentile, predicted and 5th percentile of ALT values by age for females. The X axis represents current student age. The Y
axis is the ALT level, and the top and bottom lines are the 95
th and 5
th percentile. The middle line represents the predicted values for ALT in female
participants according to age.
doi:10.1371/journal.pone.0021178.g002
Table 4. Multiple logistic regressions for predictors of ALT by
gender.
Male Female
OR 95% CI P value OR 95% CI P value
Age (for each 10
yrs)
- - - 0.75 0.66–0.88 ,0.001
Waist/hip ratio 2.25 1.4–3.56 ,0.001 1.8 1.16–2.8 ,0.001
BMI 2 1.68–2.37 0.001 1.61 1.34–1.94 ,0.001
T-C 1.42 1.14–1.77 ,0.001 1.32 1.09–1.62 ,0.001
doi:10.1371/journal.pone.0021178.t004
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as the National High Blood Pressure Education Program
(NHBPEP) recommended cut-point of the 90
th percentile for
age, gender, and height [41]. A triglyceride (TG) concentration
$100 mg/dl was considered elevated based on the criteria used to
define the metabolic syndrome in adolescents [42]. High density
lipoprotein-cholesterol (HDL-C) ,50 mg/dl was used to define a
low HDL cholesterol, except in boys aged 15–18 years, in whom
,45 mg/dl was used as the definition for low HDL cholesterol
[42]. Fasting glucose $100 mg/dl was classified as elevated based
on the recommendations of the American Diabetes Association
(2003) and the WHO (2006) [43,44]. The cut-offs for total
cholesterol (T-C ,170 mg/dl) and low density lipoprotein-
cholesterol (LDL-C ,110 mg/dl) were accepted as normal [45].
Insulin resistance was calculated using the homeostasis model
assessment of insulin resistance (HOMA-IR) [46]and insulin
resistance was defined as HOMA-IR .2 [23]. We used NCEP-
ATP III criteria to define the metabolic syndrome [47].
Fatty liver was diagnosed on an abdominal ultrasound
performed in all subjects using an ALOKA SSD 1700 machine
by an experienced radiologist, unaware of the laboratory and
other results. The presence of fatty liver was determined using
accepted criteria that included a diffuse increase in echo texture
(bright liver), increased liver echo texture compared with the
kidneys, vascular blurring and deep attenuation [48].
All data were analyzed using SPSS for Windows Version 15
(SPSS Inc, Chicago, USA). The Student’s t test and one-way
ANOVA were used for continuous variables. Non-parametric tests
were used when parametric assumptions were not met. Indepen-
dent predictors of ALT were identified by multiple logistic
regression analysis, with backward stepwise variable selection. A
p-value of #0.05 denoted significance.
The Medical Ethics Committee in Digestive Disease Research
Center approved the conduct of the current study. Study was
conducted in accord with principles of Declaration of Helsinki.
Informed consent was signed by guardians of all participating
adolescents. Data were de-identified and the personnel were blind
to the identity of subjects.
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